Carolyn Webb

Jul 23, 2024 | onlinelibrary.wiley.com | Carolyn Webb |Peter Collins |Mevin A. Philip |Turja Chakraborty

Introduction Heart failure (HF) presents a considerable global public health concern, with a prevalence of an estimated 64.3 million cases worldwide.1 Due to improvements in treatments and survival after diagnosis, together with an ageing population, the prevalence of HF is likely to rise. Now more than ever, there is interest in finding new efficacious and affordable treatment alternatives for patients with HF.